Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy

Richard S. Lee, Kazuhiko Yamada, Stuart L. Houser, Karl L. Womer, Michaella E. Maloney, Harris S. Rose, Mohamed H. Sayegh, Joren C. Madsen

Research output: Contribution to journalArticle

Abstract

Graft loss from chronic rejection has become the major obstacle to the long-term success of whole organ transplantation. In cardiac allografts, chronic rejection is manifested as a diffuse and accelerated form of arteriosclerosis, termed cardiac allograft vasculopathy. It has been suggested that T-cell recognition of processed alloantigens (allopeptides) presented by recipient antigen-presenting cells through the indirect pathway of allorecognition plays a critical role in the development and progression of chronic rejection. However, definitive preclinical evidence to support this hypothesis is lacking. To examine the role of indirect allorecognition in a clinically relevant large animal model of cardiac allograft vasculopathy, we immunized MHC inbred miniature swine with synthetic polymorphic peptides spanning the α1 domain of an allogeneic donor-derived swine leukocyte antigen class I gene. Pigs immunized with swine leukocyte antigen class I allopeptides showed in vitro proliferative responses and in vivo delayed-type hypersensitivity responses to the allogeneic peptides. Donor MHC class I disparate hearts transplanted into peptide-immunized cyclosporine-treated pigs not only rejected faster than unimmunized cyclosporine-treated controls (mean survival time = 5.5 +/-1.7 vs, 54.7 +/-3.8 days, P <0.001), but they also developed obstructive fibroproliferative coronary artery lesions much earlier than unimmunized controls (30 days). These results definitively link indirect allorecognition and cardiac allograft vasculopathy.

Original languageEnglish (US)
Pages (from-to)3276-3281
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number6
DOIs
StatePublished - Mar 13 2001
Externally publishedYes

Fingerprint

Allografts
Peptides
Cyclosporine
Swine
MHC Class I Genes
Miniature Swine
Isoantigens
Arteriosclerosis
Delayed Hypersensitivity
Organ Transplantation
Antigen-Presenting Cells
Coronary Vessels
Animal Models
T-Lymphocytes
Transplants
swine leukocyte antigen

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. / Lee, Richard S.; Yamada, Kazuhiko; Houser, Stuart L.; Womer, Karl L.; Maloney, Michaella E.; Rose, Harris S.; Sayegh, Mohamed H.; Madsen, Joren C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 6, 13.03.2001, p. 3276-3281.

Research output: Contribution to journalArticle

Lee, Richard S. ; Yamada, Kazuhiko ; Houser, Stuart L. ; Womer, Karl L. ; Maloney, Michaella E. ; Rose, Harris S. ; Sayegh, Mohamed H. ; Madsen, Joren C. / Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. In: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Vol. 98, No. 6. pp. 3276-3281.
@article{031ba034f5ad402da3f8909e5e2c434e,
title = "Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy",
abstract = "Graft loss from chronic rejection has become the major obstacle to the long-term success of whole organ transplantation. In cardiac allografts, chronic rejection is manifested as a diffuse and accelerated form of arteriosclerosis, termed cardiac allograft vasculopathy. It has been suggested that T-cell recognition of processed alloantigens (allopeptides) presented by recipient antigen-presenting cells through the indirect pathway of allorecognition plays a critical role in the development and progression of chronic rejection. However, definitive preclinical evidence to support this hypothesis is lacking. To examine the role of indirect allorecognition in a clinically relevant large animal model of cardiac allograft vasculopathy, we immunized MHC inbred miniature swine with synthetic polymorphic peptides spanning the α1 domain of an allogeneic donor-derived swine leukocyte antigen class I gene. Pigs immunized with swine leukocyte antigen class I allopeptides showed in vitro proliferative responses and in vivo delayed-type hypersensitivity responses to the allogeneic peptides. Donor MHC class I disparate hearts transplanted into peptide-immunized cyclosporine-treated pigs not only rejected faster than unimmunized cyclosporine-treated controls (mean survival time = 5.5 +/-1.7 vs, 54.7 +/-3.8 days, P <0.001), but they also developed obstructive fibroproliferative coronary artery lesions much earlier than unimmunized controls (30 days). These results definitively link indirect allorecognition and cardiac allograft vasculopathy.",
author = "Lee, {Richard S.} and Kazuhiko Yamada and Houser, {Stuart L.} and Womer, {Karl L.} and Maloney, {Michaella E.} and Rose, {Harris S.} and Sayegh, {Mohamed H.} and Madsen, {Joren C.}",
year = "2001",
month = "3",
day = "13",
doi = "10.1073/pnas.051584498",
language = "English (US)",
volume = "98",
pages = "3276--3281",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy

AU - Lee, Richard S.

AU - Yamada, Kazuhiko

AU - Houser, Stuart L.

AU - Womer, Karl L.

AU - Maloney, Michaella E.

AU - Rose, Harris S.

AU - Sayegh, Mohamed H.

AU - Madsen, Joren C.

PY - 2001/3/13

Y1 - 2001/3/13

N2 - Graft loss from chronic rejection has become the major obstacle to the long-term success of whole organ transplantation. In cardiac allografts, chronic rejection is manifested as a diffuse and accelerated form of arteriosclerosis, termed cardiac allograft vasculopathy. It has been suggested that T-cell recognition of processed alloantigens (allopeptides) presented by recipient antigen-presenting cells through the indirect pathway of allorecognition plays a critical role in the development and progression of chronic rejection. However, definitive preclinical evidence to support this hypothesis is lacking. To examine the role of indirect allorecognition in a clinically relevant large animal model of cardiac allograft vasculopathy, we immunized MHC inbred miniature swine with synthetic polymorphic peptides spanning the α1 domain of an allogeneic donor-derived swine leukocyte antigen class I gene. Pigs immunized with swine leukocyte antigen class I allopeptides showed in vitro proliferative responses and in vivo delayed-type hypersensitivity responses to the allogeneic peptides. Donor MHC class I disparate hearts transplanted into peptide-immunized cyclosporine-treated pigs not only rejected faster than unimmunized cyclosporine-treated controls (mean survival time = 5.5 +/-1.7 vs, 54.7 +/-3.8 days, P <0.001), but they also developed obstructive fibroproliferative coronary artery lesions much earlier than unimmunized controls (30 days). These results definitively link indirect allorecognition and cardiac allograft vasculopathy.

AB - Graft loss from chronic rejection has become the major obstacle to the long-term success of whole organ transplantation. In cardiac allografts, chronic rejection is manifested as a diffuse and accelerated form of arteriosclerosis, termed cardiac allograft vasculopathy. It has been suggested that T-cell recognition of processed alloantigens (allopeptides) presented by recipient antigen-presenting cells through the indirect pathway of allorecognition plays a critical role in the development and progression of chronic rejection. However, definitive preclinical evidence to support this hypothesis is lacking. To examine the role of indirect allorecognition in a clinically relevant large animal model of cardiac allograft vasculopathy, we immunized MHC inbred miniature swine with synthetic polymorphic peptides spanning the α1 domain of an allogeneic donor-derived swine leukocyte antigen class I gene. Pigs immunized with swine leukocyte antigen class I allopeptides showed in vitro proliferative responses and in vivo delayed-type hypersensitivity responses to the allogeneic peptides. Donor MHC class I disparate hearts transplanted into peptide-immunized cyclosporine-treated pigs not only rejected faster than unimmunized cyclosporine-treated controls (mean survival time = 5.5 +/-1.7 vs, 54.7 +/-3.8 days, P <0.001), but they also developed obstructive fibroproliferative coronary artery lesions much earlier than unimmunized controls (30 days). These results definitively link indirect allorecognition and cardiac allograft vasculopathy.

UR - http://www.scopus.com/inward/record.url?scp=0035853046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035853046&partnerID=8YFLogxK

U2 - 10.1073/pnas.051584498

DO - 10.1073/pnas.051584498

M3 - Article

C2 - 11248069

AN - SCOPUS:0035853046

VL - 98

SP - 3276

EP - 3281

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -